This service will help doctors deliver better-targeted treatments earlier. For patients, this means a quicker recovery, fewer complications such as sepsis, and a reduced risk of spreading infections to others.This…
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 6 March 2025, approved lazertinib (brand name Lazcluze) for adults with non-small cell lung cancer that has spread to other…
The government has today announced the appointment of Lawrence Tallon as the new Chief Executive Officer of Medicines and Healthcare products Regulatory Agency (MHRA).Following an extensive recruitment process, Mr Tallon…
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an mRNA respiratory syncytial virus (RSV) vaccine (brand name mRESVIA) to protect patients aged 60 and over against lower respiratory…
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 14 February 2025, approved efanesoctocog alfa (brand name Altuvoct) to be used to treat and prevent bleeding in patients aged…
